| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Stoke Therapeutics, Inc. (STOK) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. STOK is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.91M | $123.83M | - | |
| CEO | 380.0K | $12.05M | - | |
| Dir | 283.3K | $8.98M | - | |
| Other | 118.7K | $3.76M | - | |
| Dir | 110.9K | $3.51M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2020 | Nash Huw M.81 | COO &Cbo | Sale+OE | 47,919 | $30.00 | $1,437,570.00 | -100% | |
| Sep 1, 2020 | Nash Huw M.81 | COO &Cbo | Sale+OE | 5,700 | $27.74 | $158,112.63 | -89.1% | |
| Aug 28, 2020 | Nash Huw M.81 | COO &Cbo | Sale+OE | 2,081 | $30.00 | $62,430.00 | -100% | |
| Aug 3, 2020 | Nash Huw M.81 | COO &Cbo | Sale+OE | 5,700 | $24.73 | $140,943.33 | -100% | |
| Jul 16, 2020 | Nash Huw M.81 | COO &Cbo | Sale+OE | 1,900 | $25.06 | $47,614.00 | -100% | |
| Jul 7, 2020 | Walker Robin A. | Chief Legal Officer, CCO &Sec | Sell | 941 | $22.50 | $21,172.50 | -100% | |
| Jul 7, 2020 | Nash Huw M.81 | COO &Cbo | Sell | 913 | $22.41 | $20,456.86 | -100% | |
| Jul 1, 2020 | Nash Huw M.81 | COO &Cbo | Sale+OE | 3,800 | $23.15 | $87,967.72 | -100% | |
| Jun 1, 2020 | Ticho Barry52 | Chief Medical Officer | Sale+OE | 1,365 | $27.39 | $37,386.70 | -0.4% | |
| Jun 1, 2020 | Liau Gene | EVP Research &Preclinical Dev | Sale+OE | 20,000 | $26.35 | $527,036.83 | -28.2% |